CPH
ELGX

C Partners Holding’s Endologix Inc ELGX Stock Holding History

C Partners Holding’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,672
Closed -$867K – 52
2014
Q4 		$867K Buy
+5,672
New +$708K 0.28% 42

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

C Partners Holding's ELGX Position: Q1 2015 in Review

C Partners Holding sold out of Endologix Inc (ELGX) in Q1 2015, closing a stake of 5,672 shares — an estimated $867K sold.

C Partners Holding first reported a position in ELGX in Q4 2014 and held it in 1 quarter. The position peaked at $867K in Q4 2014. 126 funds tracked by Wall St. Rank hold ELGX as of Q1 2015.

  • C Partners Holding reported no remaining Endologix Inc position as of Q1 2015 after selling out during the quarter.
  • C Partners Holding sold 5,672 Endologix Inc shares in Q1 2015, an estimated $867K.
  • C Partners Holding first reported a position in Endologix Inc in Q4 2014 and held it in 1 quarter.
  • C Partners Holding's Endologix Inc position peaked at $867K in Q4 2014.
  • 126 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2015.

Based on C Partners Holding's 13F filing for Q1 2015, filed 21 Apr 2015.